Effect of Vaginal PH on Treatment Effectiveness With Misoprostol for First Trimester Missed Abortions
- Conditions
- MISED ABORTION- Vaginal PH
- Registration Number
- NCT01270334
- Lead Sponsor
- HaEmek Medical Center, Israel
- Brief Summary
vaginal PH has an effect on the effectiveness of treatment with misoprostol given vaginally for missed abortions in the first trimester
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
- missed abortion over 8 weeks hypersensitivity for PG vaginal bleeding suspected EUP IUD heart disease, HTN, cerebral vascular disease, epilepsy intrauterine infection clooting disorder under 18
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method treatment failure- need for D&C 2 weeks
- Secondary Outcome Measures
Name Time Method side effects, need foe analgetics, time for compliting abortion 2 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link vaginal pH to misoprostol efficacy in first-trimester missed abortions?
How does misoprostol's effectiveness in treating missed abortions compare to standard-of-care regimens like methotrexate?
Which biomarkers correlate with successful misoprostol treatment outcomes in first-trimester missed abortions?
What adverse events are associated with vaginal misoprostol administration for missed abortions and how are they managed?
Are there alternative prostaglandin analogs or combination therapies that enhance treatment outcomes for first-trimester missed abortions?
Trial Locations
- Locations (1)
Haemel Medical Center
🇮🇱Afula, Israel
Haemel Medical Center🇮🇱Afula, Israelshira baram, mdPrincipal Investigator